Related references
Note: Only part of the references are listed.The current and future aspects of glioblastoma: Immunotherapy a new hope?
Vimal Patel et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2021)
Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Anoop P. Patel et al.
LANCET NEUROLOGY (2019)
Frequency determination of breast tumor-reactive CD4 and CD8 T cells in humans: unveiling the antitumor immune response
Mariana Pereira Pinho et al.
ONCOIMMUNOLOGY (2019)
Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy
Thiago A. Patente et al.
FRONTIERS IN IMMUNOLOGY (2019)
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Linda M. Liau et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Immunotherapy Approaches in the Treatment of Malignant Brain Tumors
Anastasie M. Dunn-Pirio et al.
CANCER (2017)
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
Martin J. van den Bent et al.
LANCET (2017)
Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cells
Mariana Pereira Pinho et al.
CYTOTHERAPY (2016)
Deregulation of SOCS5 suppresses dendritic cell function in chronic lymphocytic leukemia
Patricia A. Toniolo et al.
ONCOTARGET (2016)
Immunotherapy for glioblastoma: concepts and challenges
Tobias Weiss et al.
CURRENT OPINION IN NEUROLOGY (2015)
Immunotherapy advances for glioblastoma
David A. Reardon et al.
NEURO-ONCOLOGY (2014)
Molecularly targeted therapies for recurrent glioblastoma: current and future targets
Darryl Lau et al.
NEUROSURGICAL FOCUS (2014)
What Are the Molecules Involved in Regulatory T-Cells Induction by Dendritic Cells in Cancer?
Rodrigo Nalio Ramos et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Are dysfunctional monocyte-derived dendritic cells in cancer an explanation for cancer vaccine failures?
Jose Alexandre et al.
IMMUNOTHERAPY (2013)
Decisions About Dendritic Cells: Past, Present, and Future
Ralph M. Steinman
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Monocyte-derived dendritic cells from breast cancer patients are biased to induce CD4+CD25+Foxp3+ regulatory T cells
Rodrigo Nalio Ramos et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
Th17 cells in cancer: help or hindrance?
Cailin Moira Wilke et al.
CARCINOGENESIS (2011)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Dendritic cell-tumor cell hybrid vaccination for metastatic cancer
JAM Barbuto et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Share Paper
